Zinc Supplement in Regorafenib Treated mCRC Patient
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Phase II randomized trial to investigate whether supplementation of zinc decreases the incidence of HFSR that occurs after treatment of tyrosine kinase inhibitor, regorafenib.
创建时间：
2016-03-15
